Results 71 to 80 of about 16,174 (186)

A Clinical Practice Guideline for the Management of Patients With Acute Spinal Cord Injury: Recommendations on the Type and Timing of Anticoagulant Thromboprophylaxis

Global Spine Journal, 2017
Introduction: The objective of this study is to develop evidence-based guidelines that recommend effective, safe and cost-effective thromboprophylaxis strategies in patients with spinal cord injury (SCI).
Michael G. Fehlings MD, PhD, FRCSC, FACS, Lindsay A. Tetreault PhD, Bizhan Aarabi MD, Paul Anderson MD, Paul M. Arnold MD, Darrel S. Brodke MD, Anthony S. Burns MD, PhD, Kazuhiro Chiba MD, PhD, Joseph R. Dettori PhD, MPH, Julio C. Furlan MD, PhD, Gregory Hawryluk MD, PhD, Langston T. Holly MD, Susan Howley BA, Tara Jeji MD, Sukhvinder Kalsi-Ryan PhD, Mark Kotter PhD, Shekar Kurpad MD, PhD, Brian K. Kwon MD, PhD, Ralph J. Marino MD, Allan R. Martin MD, Eric Massicotte MD, Geno Merli MD, James W. Middleton HBBS, PhD, Hiroaki Nakashima MD, Narihito Nagoshi MD, Katherine Palmieri MD, Anoushka Singh PhD, Andrea C. Skelly PhD, Eve C. Tsai MD, PhD, Alexander Vaccaro MD, PhD, Jefferson R. Wilson MD, PhD, Albert Yee MD, James S. Harrop MD   +32 more
doaj   +1 more source

An update on prevention of venous thromboembolism in hospitalized acutely ill medical patients

Thrombosis Journal, 2006
Both the recently updated consensus guidelines published by the American College of Chest Physicians, and the International Union of Angiology recommend thromboprophylaxis with either low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH) in
Kleber Franz-Xaver, Samama Meyer
doaj   +1 more source

Prevention of venous thromboembolism in cancer patients: current approaches and opportunities for improvement

Oncology Reviews, 2011
Venous thromboembolism (VTE), a common complication in patients with cancer, is associated with increased risk of morbidity, mortality, and recurrent VTE.
Alpesh N. Amin, Steven B. Deitelzweig
doaj   +1 more source

STAMP: surgical thromboprophylaxis adherence management programme

BMJ Open Quality
Introduction Venous thromboembolism is the main cause of preventable in-hospital morbidity and mortality. Despite the recommendations available in the clinical practice guideline, there is low adherence to correct thromboprophylaxis.
Natalia Quintana-Montejo, Paulo Andres Cabrera Rivera, Stefany de Jesús Ríos Acuña, Danna Lesley Cruz Reyes   +3 more
doaj   +1 more source

Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis

World Journal of Surgical Oncology
Background Direct oral anticoagulants (DOACs) used as an alternative to low-molecular-weight heparin (LMWH) for thromboprophylaxis after cancer surgery for venous thromboembolic events (VTE) remains unclear.
Hong Zhou, Ting-Ting Chen, Ling-ling Ye, Jun-Jie Ma, Jin-Hua Zhang   +4 more
doaj   +1 more source

Abstracts from the 2026 Congress of the Scandinavian Society of Anesthesiology and Intensive Care Medicine, Reykjavik, Iceland, June 10–12, 2026

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 9, October 2026.
wiley   +1 more source

Anticoagulant therapy in orthopedic surgery – a review on anticoagulant agents, risk factors, monitoring, and current challenges

Journal of Orthopaedic Surgery
Orthopedic surgeries are associated with high-risk of thromboembolism which occurs in 40% to 60% of orthopedic patients in the absence of thromboprophylaxis. Conventionally heparin anticoagulants were used for thromboprophylaxis and currently direct oral
Yiqun Wang, Xiaobin Xu, Wei Zhu
doaj   +1 more source

Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey

Endocrine Connections
Background: Patients with Cushing syndrome (CS) are at increased risk of venous thromboembolism (VTE). Objective: The aim was to evaluate the current management of new cases of CS with a focus on VTE and thromboprophylaxis.
M Cherenko, N M Appelman-Dijkstra, A L Priego Zurita, N R Biermasz, O M Dekkers, F A Klok, N Reisch, A Aulinas, B Biagetti, S Cannavo, L Canu, M Detomas, F Devuyst, H Falhammar, R A Feelders, F Ferrau, F Gatto, C Grasselli, P van Houten, C Hoybye, A M Isidori, A Kyrilli, P Loli, D Maiter, E Nowak, R Pivonello, O Ragnarsson, R V Steenaard, N Unger, A van de Ven, S M Webb, D Yeste, S F Ahmed, A M Pereira   +33 more
doaj   +1 more source

Meta-analysis of Randomized Trials in Emergency and Acute Orthopedic Trauma Comparing Aspirin and Low-Molecular-Weight Heparin for Thromboprophylaxis. [PDF]

Orthop Rev (Pavia)
Alshehri AF, Samarkandi WO, Muhanad L, Mesri HE, Bin Salleeh OH, AlAmiri AM, Bukhari AA, Alshehri AM, Alrajeh AA, Alrazoq FA, Alshawaf AA, Alzamel AA, Alsheikh Tahboub MM, Albadawi MI, Alqahtani SS.   +14 more
europepmc   +1 more source

Real-World Outcomes of Thromboprophylaxis With Apixaban in Patients With Newly Diagnosed Multiple Myeloma, the MyelMeXa Study. [PDF]

EJHaem
Sanchez KA, Cesarman-Maus G, Flores-Cruz M, Cabello B, Espinoza R, Fernandez-Vargas OE.   +5 more
europepmc   +1 more source